Increasing doxorubicin activity against breast cancer cells using PPARγ-ligands and by exploiting circadian rhythms
about
Melatonin, an inhibitory agent in breast cancer.A new dawn for the use of thiazolidinediones in cancer therapy.Melatonin Prevents Mitochondrial Damage Induced by Doxorubicin in Mouse Fibroblasts Through Ampk-Ppar Gamma-Dependent Mechanisms.Cell death and restoration of TRAIL-sensitivity by ciglitazone in resistant cervical cancer cells.Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.Functional activation of PPARγ in human upper aerodigestive cancer cell lines.
P2860
Increasing doxorubicin activity against breast cancer cells using PPARγ-ligands and by exploiting circadian rhythms
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Increasing doxorubicin activit ...... y exploiting circadian rhythms
@en
type
label
Increasing doxorubicin activit ...... y exploiting circadian rhythms
@en
prefLabel
Increasing doxorubicin activit ...... y exploiting circadian rhythms
@en
P2093
P2860
P356
P1476
Increasing doxorubicin activit ...... y exploiting circadian rhythms
@en
P2093
P2860
P304
P356
10.1111/BPH.12202
P407
P577
2013-07-01T00:00:00Z